(Q47956330)

7 February 2018

title

Evaluation of early atherosclerosis in patients with inflammatory bowel disease (English)

1 reference

7 February 2018

inflammatory bowel diseases

0 references

1 reference

1 reference

Hasan Kayahan

1

1 reference

7 February 2018

Ismail Sari

2

1 reference

7 February 2018

Nesat Cullu

3

1 reference

7 February 2018

Fahize Yuksel

4

1 reference

7 February 2018

Serdal Demir

5

1 reference

7 February 2018

Mesut Akarsu

6

1 reference

7 February 2018

Yigit Goktay

7

1 reference

7 February 2018

Belkis Unsal

8

1 reference

7 February 2018

Hale Akpinar

9

1 reference

7 February 2018

publication date

1 April 2012

1 reference

7 February 2018

Digestive Diseases and Sciences

published in

1 reference

7 February 2018

volume

57

1 reference

7 February 2018

issue

8

1 reference

7 February 2018

page(s)

2137-2143

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1007/s10620-012-2148-x

exact match

0 references

cites work

Inflammation in atherosclerosis: from pathophysiology to practice

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2148-X

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2148-X

21 January 2018

Flow-mediated dilatation

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2148-X

Intima-media thickness: indicator of cardiovascular risk and measure of the extent of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2148-X

Inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2148-X

Inflammatory bowel disease is associated with an increased incidence of cardiovascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2148-X

Evidence of endothelial dysfunction in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2148-X

Increased carotid intima-media thickness in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2148-X

Endothelial dysfunction in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2148-X

Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2148-X

Is inflammatory bowel disease a risk factor for early atherosclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2148-X

Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2148-X

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2148-X

Inflammatory markers and the risk of coronary heart disease in men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2148-X

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2148-X

Impaired endothelial function in patients with ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2148-X

An update on the relationships between rheumatoid arthritis and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2148-X

Thromboembolism in inflammatory bowel disease: role of platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2148-X

Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2148-X

CD40 and its ligand in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2148-X

CD40 ligand: a novel target in the fight against cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2148-X

Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2148-X

Extraintestinal manifestations of inflammatory bowel disease

21 January 2018

1 reference

12 December 2020

Association between enhanced soluble CD40 ligand and prothrombotic state in inflammatory bowel disease

1 reference

12 December 2020

Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease

1 reference

12 December 2020

Inflammatory bowel disease is not associated with increased intimal media thickening

1 reference

12 December 2020

Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden

1 reference

12 December 2020

Platelet-derived CD40L: the switch-hitting player of cardiovascular disease

1 reference

12 December 2020

Intima-media thickness of the common carotid artery is not significantly higher in Crohn's disease patients compared to healthy population

1 reference

12 December 2020

Atherosclerosis in systemic lupus erythematosus

1 reference

12 December 2020

Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease

1 reference

12 December 2020

10.1007/S10620-012-2148-X

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018